CCEL Q4 2024 Earnings — Cryo-Cell International, Inc. Revenue & Financial Results | Market Cap Arena

CCELCryo-Cell International, Inc.

$26M

Q4 2024 Earnings

Healthcare Medical - Care Facilities

Income Statement

Revenue

$8M+1.9% YoY

Gross Profit

$6M79.6% margin

Operating Income

-$122,347-1.5% margin

Net Income

-$2M-23.2% margin

EPS (Diluted)

$-0.23

QoQ Revenue Growth

-0.5%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

$2M

Stock-Based Comp.

$149,693

Balance Sheet

Total Assets

$65M

Total Liabilities

$78M

Stockholders' Equity

-$13M

Cash & Equivalents

$560,960

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$8M	+1.9%
Gross Profit	$6M	$6M	+10.1%
Operating Income	-$122,347	-$16M	+99.2%
Net Income	-$2M	-$11M	+83.4%

Revenue Segments

Processing And Storage Fees

$8M98%

Public Banking

$160,8732%

Product

$28,4140%